The 2026 Strategic Outlook: Navigating the Global Neurosyphilis Market
As of early 2026, the global neurosyphilis market has emerged as a high-stakes segment of the infectious disease vertical. Valued at approximately $0.78 billion in 2025 and projected to reach $1.21 billion by 2035, the market is growing at a CAGR of 4.43%. This resurgence is driven by an alarming global rise in syphilis incidence—up … Read more